Pathogen Inactivation: Mechanisms of Action and in vitro Efficacy of Various Agents (original) (raw)
Plasma/platelet pathogen inactivation
Torunn Apelseth
ISBT Science Series, 2006
View PDFchevron_right
Pathogen inactivation treatment of plasma and platelet concentrates and their predicted functionality in massive transfusion protocols
Brankica Culibrk
Transfusion, 2017
View PDFchevron_right
Pathogen reduction/inactivation of products for the treatment of bleeding disorders: what are the processes and what should we say to patients?
Hermann Eichler
Annals of hematology, 2017
View PDFchevron_right
The clinical and biological impact of new pathogen inactivation technologies on platelet concentrates
Jean-daniel Tissot
Blood Reviews, 2014
View PDFchevron_right
Pathogen inactivation of platelets with a photochemical treatment with amotosalen HCl and ultraviolet light: process used in the SPRINT trial
Edwin Burgstaler
Transfusion, 2006
View PDFchevron_right
Photochemical treatment of plasma with amotosalen and long-wavelength ultraviolet light inactivates pathogens while retaining coagulation function
Lily Lin
Transfusion, 2006
View PDFchevron_right
Helinx technology for inactivation of infectious pathogens and leukocytes in labile blood components: from theory to clinical application
L. Corash
Transfusion and Apheresis Science, 2001
View PDFchevron_right
Transfusion of pooled buffy coat platelet components prepared with photochemical pathogen inactivation treatment: the euroSPRITE trial
Lily Lin
2002
View PDFchevron_right
Pathogen-reduced platelets for the prevention of bleeding
Susan Brunskill, Marialena Trivella
The Cochrane database of systematic reviews, 2013
View PDFchevron_right
Reflections on the dynamics of bacterial and viral contamination of blood components and the levels of efficacy for pathogen inactivation processes
Marcia Cardoso
Transfusion and Apheresis Science, 2018
View PDFchevron_right
A prospective observational cohort safety study of 5106 platelet transfusions with components prepared with photochemical pathogen inactivation treatment
Aurora Espinosa
Transfusion, 2008
View PDFchevron_right
Current debate on pathogen inactivation of platelet concentrates – To use or not to use?
Torunn Apelseth
Transfusion and Apheresis Science, 2010
View PDFchevron_right
Development of the S-303 Pathogen Inactivation Technology for Red Blood Cell Concentrates
Reinhard Henschler
Transfusion Medicine and Hemotherapy, 2011
View PDFchevron_right
Universal adoption of pathogen inactivation of platelet components: impact on platelet and red blood cell component use
Maryse van Hooydonk
Transfusion, 2009
View PDFchevron_right
The Use of Solvent/Detergent Treatment in Pathogen Reduction of Plasma
Bjarte Solheim
Transfusion Medicine and Hemotherapy, 2011
View PDFchevron_right
Antioxidant power as a quality control marker for completeness of amotosalen and ultraviolet A photochemical treatments in platelet concentrates and plasma units
Philippe Tacchini
Transfusion, 2016
View PDFchevron_right
A process for solvent/detergent treatment of plasma for transfusion at blood centers that use a disposable‐bag system
Makram Sayed
…, 2006
View PDFchevron_right
Defining “adequate” pathogen reduction performance for transfused blood components
Michael P Busch
Transfusion, 2010
View PDFchevron_right
Protecting the Blood Supply From Emerging Pathogens: The Role of Pathogen Inactivation
Lily Lin
Transfusion Medicine Reviews, 2005
View PDFchevron_right
Clinical trials for pathogen reduction in transfusion medicine: A review
Mina Xu
Transfusion and Apheresis Science, 2009
View PDFchevron_right
Inactivation of infectious pathogens in labile blood components: meeting the challenge
L. Corash
Transfusion Clinique et Biologique, 2001
View PDFchevron_right
Blood sterilisation by PDT: study of photosensitiser toxicity on red blood cells
Egbert Piasecki
View PDFchevron_right
Pathogen inactivation: making decisions about new technologies - preliminary report of a consensus conference
Jeffrey Hoch
Vox Sanguinis, 2007
View PDFchevron_right
Oxygen removal during pathogen inactivation with riboflavin and UV light preserves protein function in plasma for transfusion
Hendrik Feys
View PDFchevron_right
Reducing the risk of infection from plasma products: specific preventative strategies
T. Burnouf
Blood Reviews, 2000
View PDFchevron_right
Evaluation of bacterial inactivation in prestorage pooled, leukoreduced, whole blood?derived platelet concentrates suspended in plasma prepared with photochemical treatment
L. Corash
Transfusion, 2007
View PDFchevron_right
‘Sterility Testing of Blood Components and Advanced Therapy Medicinal Products’ (Munich, April 29, 2010) Organized by the DGTI Section ‘Safety in Hemotherapy’ – Abstracts
Cohava Gelber
Transfusion Medicine and Hemotherapy, 2011
View PDFchevron_right
Improving the safety of whole blood-derived transfusion products with a riboflavin-based pathogen reduction technology
Marcia Cardoso
Blood transfusion = Trasfusione del sangue, 2017
View PDFchevron_right